196 related articles for article (PubMed ID: 31220961)
1. Characteristics of Breakthrough Pain and Its Impact on Quality of Life in Terminally Ill Cancer Patients.
Gonella S; Sperlinga R; Sciannameo V; Dimonte V; Campagna S
Integr Cancer Ther; 2019; 18():1534735419859095. PubMed ID: 31220961
[No Abstract] [Full Text] [Related]
2. Alberta Breakthrough Pain Assessment Tool: A validation multicentre study in cancer patients with breakthrough pain.
Sperlinga R; Campagna S; Berruti A; Laciura P; Ginosa I; Paoletti S; Giuliano PL; Tucci M; Rosato R; Scagliotti GV; Saini A
Eur J Pain; 2015 Aug; 19(7):881-8. PubMed ID: 25370838
[TBL] [Abstract][Full Text] [Related]
3. A randomized, placebo-controlled study of a new sublingual formulation of fentanyl citrate (fentanyl ethypharm) for breakthrough pain in opioid-treated patients with cancer.
Novotna S; Valentova K; Fricova J; Richterova E; Harabisova S; Bullier F; Trinquet F;
Clin Ther; 2014 Mar; 36(3):357-67. PubMed ID: 24508417
[TBL] [Abstract][Full Text] [Related]
4. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
Simpson DM; Messina J; Xie F; Hale M
Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
[TBL] [Abstract][Full Text] [Related]
5. Circadian variation of breakthrough pain in cancer patients.
Saini A; Tucci M; Tampellini M; Maina D; Bouraouia K; Giuliano PL; Termine A; Castellano M; Campagna S; Laciura P; Berruti A
Eur J Pain; 2013 Feb; 17(2):264-70. PubMed ID: 22715071
[TBL] [Abstract][Full Text] [Related]
6. Breakthrough Cancer Pain: Preliminary Data of The Italian Oncologic Pain Multisetting Multicentric Survey (IOPS-MS).
Mercadante S; Marchetti P; Cuomo A; Caraceni A; Mediati RD; Mammucari M; Natoli S; Lazzari M; Dauri M; Airoldi M; Azzarello G; Bandera M; Blasi L; Cartenì G; Chiurazzi B; Costanzo BVP; Degiovanni D; Fusco F; Guardamagna V; Iaffaioli V; Liguori S; Lorusso V; Mameli S; Mattioli R; Mazzei T; Melotti RM; Menardo V; Miotti D; Moroso S; De Santis S; Orsetti R; Papa A; Ricci S; Sabato AF; Scelzi E; Sofia M; Tonini G; Aielli F; Valle A;
Adv Ther; 2017 Jan; 34(1):120-135. PubMed ID: 27873235
[TBL] [Abstract][Full Text] [Related]
7. Sublingual Fentanyl Tablets for Relief of Breakthrough Pain in Cancer Patients and Association with Quality-of-Life Outcomes.
Guitart J; Vargas MI; De Sanctis V; Folch J; Salazar R; Fuentes J; Coma J; Ferreras J; Moya J; Tomás A; Estivill P; Rodelas F; Jiménez AJ
Clin Drug Investig; 2015 Dec; 35(12):815-22. PubMed ID: 26507617
[TBL] [Abstract][Full Text] [Related]
8. Italian Oncological Pain Survey (IOPS): a multicentre Italian study of breakthrough pain performed in different settings.
Mercadante S; Lazzari M; Reale C; Cuomo A; Fusco F; Marchetti P; Mediati RD; Chiurazzi B; Ciuffedra L; Caraceni A; Iaffaioli V; Luzzani M; Micheletto G; Papa A; Raffaeli W; Valle A; Caruso M; Di Costanzo F; Pinato G; Nardi F; Barni S; Natoli S; Mammucari M; Sabato AF; Dauri M;
Clin J Pain; 2015 Mar; 31(3):214-21. PubMed ID: 25654429
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of breakthrough cancer pain and its influence on quality of life in an international cohort of patients with cancer.
Hjermstad MJ; Kaasa S; Caraceni A; Loge JH; Pedersen T; Haugen DF; Aass N;
BMJ Support Palliat Care; 2016 Sep; 6(3):344-52. PubMed ID: 27342412
[TBL] [Abstract][Full Text] [Related]
10. Impact of breakthrough pain on community-dwelling cancer patients: results from the National Breakthrough Pain Study.
Katz NP; Gajria KL; Shillington AC; Stephenson JJ; Harshaw Q
Postgrad Med; 2017 Jan; 129(1):32-39. PubMed ID: 27846789
[TBL] [Abstract][Full Text] [Related]
11. Retrospective Observational Study on the Characteristics of Pain and Associated Factors of Breakthrough Pain in Advanced
Fan R; Li X; Yang S; Bu X; Chen Y; Wang Y; Qiu C
Pain Res Manag; 2022; 2022():8943292. PubMed ID: 35463627
[TBL] [Abstract][Full Text] [Related]
12. Breakthrough pain in community-dwelling patients with cancer pain and noncancer pain, part 1: prevalence and characteristics.
Portenoy RK; Bruns D; Shoemaker B; Shoemaker SA
J Opioid Manag; 2010; 6(2):97-108. PubMed ID: 20481174
[TBL] [Abstract][Full Text] [Related]
13. A randomized, double-blind, placebo-controlled study of fentanyl buccal tablets for breakthrough pain: efficacy and safety in Japanese cancer patients.
Kosugi T; Hamada S; Takigawa C; Shinozaki K; Kunikane H; Goto F; Tanda S; Shima Y; Yomiya K; Matoba M; Adachi I; Yoshimoto T; Eguchi K
J Pain Symptom Manage; 2014 Jun; 47(6):990-1000. PubMed ID: 24099893
[TBL] [Abstract][Full Text] [Related]
14. Fentanyl buccal tablet.
Messina J; Darwish M; Fine PG
Drugs Today (Barc); 2008 Jan; 44(1):41-54. PubMed ID: 18301803
[TBL] [Abstract][Full Text] [Related]
15. Impact of breakthrough pain on quality of life in patients with chronic, noncancer pain: patient perceptions and effect of treatment with oral transmucosal fentanyl citrate (OTFC, ACTIQ).
Taylor DR; Webster LR; Chun SY; Reinking J; Stegman M; Shoemaker S; Fortner B
Pain Med; 2007 Apr; 8(3):281-8. PubMed ID: 17371416
[TBL] [Abstract][Full Text] [Related]
16. The use of sublingual fentanyl for breakthrough pain by using doses proportional to opioid basal regimen.
Mercadante S; Prestia G; Casuccio A
Curr Med Res Opin; 2013 Nov; 29(11):1527-32. PubMed ID: 23869428
[TBL] [Abstract][Full Text] [Related]
17. The Circadian Rhythm of Breakthrough Pain Episodes in Terminally-ill Cancer Patients.
Campagna S; Sperlinga R; Milo A; Sannuto S; Acquafredda F; Saini A; Gonella S; Berruti A; Scagliotti GV; Tampellini M
Cancers (Basel); 2018 Dec; 11(1):. PubMed ID: 30586878
[TBL] [Abstract][Full Text] [Related]
18. Breakthrough pain in community-dwelling patients with cancer pain and noncancer pain, part 2: impact on function, mood, and quality of life.
Portenoy RK; Bruns D; Shoemaker B; Shoemaker SA
J Opioid Manag; 2010; 6(2):109-16. PubMed ID: 20481175
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the quality of care of elderly patients with chronic and breakthrough pain treated with opioids: SAND study.
Rodríguez MJ; de la Torre R; Ortega JL; Trinidad JM; Benítez D; Jiménez AJ; Sanz-Yagüe A; Soler B; Torres LM
Curr Med Res Opin; 2018 Apr; 34(4):701-709. PubMed ID: 28914555
[TBL] [Abstract][Full Text] [Related]
20. [A New Therapeutic Approach for Cancer-Related Breakthrough Pain - Focused on Oral Transmucosal Fentanyl].
Yomiya K; Kaneshima M; Kyosaka B; Warita E; Hosonuma R; Osato S
Gan To Kagaku Ryoho; 2017 Apr; 44(4):289-293. PubMed ID: 28428506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
